相关实验视频

Updated: Jan 7, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

EP9158H:一种免疫信息学设计的mRNA疫苗,编码多位抗原和双TLR抗原剂,用于预防结核病

Mingming Zhang^1,2, Syed Luqman Ali³, Yuan Tian²

¹Senior Department of Tuberculosis, Chinese PLA General Hospital, Beijing 100091, China.

Bioengineering (Basel, Switzerland)

|December 30, 2025

概括

一种新的mRNA疫苗候选人EP9158H是使用免疫信息学设计的,用于对抗结核病 (TB). 它整合了保存的表位和双TLR激动因子,以增强免疫反应,为当前的结核病疫苗提供了一个有希望的替代方案.

科学领域:

免疫学和疫苗学免疫学和疫苗学
计算生物学计算生物学
传染性疾病传染性疾病

背景情况:

结核病 (TB) 是一个重大的全球卫生挑战.
目前的BCG疫苗对成人肺结核的疗效有限,需要开发新的疫苗.
采用免疫信息学方法来设计一种新的mRNA结核病疫苗候选剂.

研究的目的:

使用理性免疫信息学方法设计一种新的mRNA肺结核疫苗候选剂.
识别和组装具有双重托尔类受体 (TLR) 激动剂的最佳T细胞和B细胞表位.
评估设计的候选疫苗的计算特性,稳定性和预测免疫性.

主要方法:

从13个结核病抗原中选择了最佳的T细胞 (CTL,HTL) 和B细胞表位.
将选定的表位物组装成与TLR2和TLR4激动剂 (ESAT-6和HBHA) 的支架.
执行了主要候选者EP9158H的结构建模,分子动力学,对接,免疫模拟,RNA折叠和保存分析.

主要成果:

确定了EP9158H作为最佳候选者,包含15个CTL,9个HTL和8个B细胞表位,具有双TLR2/4的激进作用.
在Mycobacterium结核病综合体 (MTBC) 血统中显示出高表位保护 (> 81%).
展示了有利的预测性质,包括高溶解度,广泛的人口覆盖,最佳对接得分,结构稳定性,强大的Th1偏倚免疫反应和稳定的mRNA二次结构.

结论:

EP9158H代表了一种有前途的新型mRNA结核病疫苗候选人,它结合了广泛的表位组覆盖和双重天生的免疫激活.
疫苗设计利用mRNA技术增强CTL诱导,并与单抗原疫苗相比提供更好的菌株覆盖.
计算验证证实了EP9158H的潜力,需要进一步进行实验研究和验证.

关键词:

这是一种TLR激动剂.免疫模拟的免疫模拟免疫信息学是一种免疫信息学.这是mRNA疫苗.分子动力学分子动力学结核病是一种肺结核病.

更多相关视频

Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System

Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System

Published on: January 31, 2018

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

相关概念视频

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...